Phase II study of the combination of cetuximab and weekly paclitaxel in the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of head and neck
2012 ◽
Vol 23
(4)
◽
pp. 1016-1022
◽
R. Hitt
◽
A. Irigoyen
◽
H. Cortes-Funes
◽
J.J. Grau
◽
J.A. García-Sáenz
◽
...
K.J. Harrington
◽
W.N. William
◽
A. Khilnani
◽
A.P. Algazi
2021 ◽
Vol 32
◽
pp. S1432
D.A. Colevas
◽
K. Misiukiewicz
◽
A.T. Pearson
◽
J. Fayette
◽
J.R. Bauman
◽
...
2016 ◽
Vol 27
◽
pp. vi334
◽
J. Guigay
◽
E. Chamorey
◽
P. Céruse
◽
F. Mornex
◽
M. Degardin
◽
...
2011 ◽
Vol 29
(15_suppl)
◽
pp. 5567-5567
◽
J. Guigay
◽
J. Fayette
◽
A. Dillies
◽
C. Sire
◽
J. N. Kerger
◽
...
G. Obara
◽
J. Sun
◽
D. Loo
◽
C. Bohac
2018 ◽
Vol 29
(4)
◽
pp. 1004-1009
◽
M. Tahara
◽
N. Kiyota
◽
T. Yokota
◽
Y. Hasegawa
◽
K. Muro
◽
...
Close
Export Citation Format
Close
Share Document
Close